Abstract
THE enzyme ornithine decarboxylase is the key regulator of the synthesis of polyamines1–3 which are essential for cell proliferation4,5. Expression of this enzyme is transiently increased upon stimulation by growth factors1–3, but becomes constitutively activated during cell transformation induced by carcinogens6,7, viruses8–10 or oncogenes11–14. To test whether ornithine decarboxylase could be a common mediator of transformation and oncogenic itself, we transfected NIH3T3 cells with expression vectors carrying the complementary DN A encoding human ornithine decarboxylase in sense and antisense orientations. The increased expression of the enzyme (50–100-times endogenous levels) induced not only cell transformation, but also anchorage-independent growth in soft agar and increased tyrosine phosphorylation of a protein of Mr130K. Expression of ornithine decarboxylase antisense RNA was associated with an epithelioid morphology and reduced cell proliferation. Moreover, blocking the endogenous enzyme using specific inhibitor or synthesizing antisense RNA prevented transformation of rat fibroblasts by temperature-sensitive v-src oncogene. Our results imply that the gene encoding ornithine decarboxylase is a proto-oncogene central for regulation of cell growth and transformation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tabor, C. W. & Tabor, H. A. Rev. Biochem. 53, 749–790 (1984).
Pegg, A. E. Biochem. J. 234, 249–262 (1986).
Heby, O. & Persson, L. Trends biochem. Sci. 15, 153–158 (1990).
Steglich, C., Grens, A. & Scheffler, I. E. Somatic Cell molec. Gen. 11, 11–23 (1985).
Pohjanpelto, P., Hölttä, E. & Jänne, O. A. Molec. cell Biol. 5, 1385–1390 (1985).
Yuspa, S. H. et al. Nature 262, 402–404 (1976).
Gilmour, S. K., Verma, A. K., Madara, T. & O'Brien, T. G. Cancer Res. 47, 1221–1225 (1987).
Don, S. & Bachrach, U. Cancer Res. 35, 3618–3622 (1975).
Gazdar, A. F., Stull, H. B., Kilton, L. J. & Bachrach, U. Nature 262, 696–698 (1976).
Haddox, M. K., Magun, B. E. & Russell, D. H. Cancer Res. 40, 604–608 (1980).
Hölttä, E., Sistonen, L. & Alitalo, K. J. biol. Chem. 263, 4500–4507 (1988).
Chang, B. K., Libby, P. R., Bergeron, R. & Porter, C. W. Biochem. biophys. Res. Commun. 157, 264–270 (1988).
Sistonen, L., Hölttä, E., Mäkelä, T. P., Keski-Oja, J. & Alitalo, K. EMBO J. 8, 815–822 (1989).
Sistonen, L., Hölttä, E., Lehväslaiho, H., Lehtola, L. & Alitalo, K. J. Cell Biol. 109, 1911–1919 (1989).
Pohjanpelto, P., Virtanen, I. & Hölttä, E. Nature 293, 475–477 (1981).
Balasundaram, D., Tabor, C. W. & Tabor, H. Proc. natn. Acad. Sci. U.S.A. 88, 5872–5876 (1991).
Southern, P. J. & Berg, P. J. molec. appl. Genet. 1, 327–341 (1982).
Metcalf, B. W. et al. J. Am. chem. Soc. 100, 2551–2553 (1978).
Erikson, R. L., Purchio, A. F., Erikson, E., Collett, M. S. & Bruggs, J. S. Cell Biol. 87, 319–325 (1980).
Sefton, B. M., Hunter, T., Beemon, K. & Eckhart, W. Cell 20, 807–816 (1980).
Ellis, C., Moran, M., McCormick, F. & Pawson, T. Nature 343, 377–381 (1990).
Hibshoosh, H., Johnson, M. & Weinstein, I. B. Oncogene 6, 739–743 (1991).
Jänne, J., Hölttä, E., Kallio, A. & Käpyaho, K. Spec Top. endocrin. Metab. 5, 227–293 (1983).
Luk, G. D. & Baylin, S. B. New Engl. J. Med. 311, 80–83 (1984).
Pegg, A. E. Cancer Res. 48, 759–774 (1988).
Katz, A. & Kahana, C. EMBO J. 8, 1163–1167 (1989).
Tonin, P. N., Yeger, H., Stallings, R. L., Srinivasan, P. R. & Lewis, W. H. Oncogene 4, 1117–1121 (1989).
Seiler, N. et al. Cancer Res. 50, 5077–5083 (1990).
Hickock, N. J., Seppänen, P. J., Gunsalus, G. L. & Jänne, O. A. DNA 6, 179–187 (1987).
Mäkelä, T. P., Partanen, J., Schwab, M. & Alitalo, K. Gene 118, 293–294 (1992).
Gunning, P., Leavitt, J., Muscat, G., Ng, S-Y. & Kedes, L. Proc. natn. Acad. Sci U.S.A. 84, 4831–4835 (1987).
Jänne, O. A., Kontula, K. K., Isomaa, V. V. & Bardin, C. W. Ann. N.Y. Acad. Sci. 438, 72–84 (1984).
Sambrook, J., Fritsch, E. F. & Maniatis, T. Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press, New York, 1989).
Kamps, M. P. & Sefton, B. M. Oncogene 2, 305–315 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Auvinen, M., Paasinen, A., Andersson, L. et al. Ornithine decarboxylase activity is critical for cell transformation. Nature 360, 355–358 (1992). https://doi.org/10.1038/360355a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/360355a0
This article is cited by
-
Polyamines: their significance for maintaining health and contributing to diseases
Cell Communication and Signaling (2023)
-
The oncogenic properties of the EWSR1::CREM fusion gene are associated with polyamine metabolism
Scientific Reports (2023)
-
Hyperglycemic conditions proliferate triple negative breast cancer cells: role of ornithine decarboxylase
Breast Cancer Research and Treatment (2021)
-
Food components and contaminants as (anti)androgenic molecules
Genes & Nutrition (2017)
-
Structural basis of Ornithine Decarboxylase inactivation and accelerated degradation by polyamine sensor Antizyme1
Scientific Reports (2015)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.